comparemela.com
Home
Live Updates
Bazhenova Details Potential Pathways Forward for Targeting KRAS Mutations in NSCLC : comparemela.com
Bazhenova Details Potential Pathways Forward for Targeting KRAS Mutations in NSCLC
Lyudmila A. Bazhenova, MD, discusses upcoming inhibitors of interest in the combination therapy space for patients with KRAS G12C–mutant NSCLC.
Related Keywords
California ,
United States ,
San Diego ,
Lyudmilaa Bazhenova ,
,
International Lung Cancer Congress ,
Uc San Diego Health ,
Annual International Lung Cancer ,
Diego Health ,
Patients With Kras G12c Mutant Advanced Non Small Cell Lung Cancer ,
D ,
Krystal 1 Trial ,
Nct03785249 ,
Codebreak 100 Trial ,
Nct03600883 ,
comparemela.com © 2020. All Rights Reserved.